Skip to main content
Article thumbnail
Location of Repository

Synergy Between Adiposity, Insulin Resistance, Metabolic Risk Factors, and Inflammation in Adolescents

By Rae-Chi Huang, Trevor A. Mori, Valerie Burke, John Newnham, Fiona J. Stanley, Louis I. Landau, Garth E. Kendall, Wendy H. Oddy and Lawrence J. Beilin
Topics: Original Research
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2660473
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1978). Albers JJ: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high densitylipoproteincholesterol.JLipidRes 19:65–76,
    2. (2000). Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study.
    3. (1996). An efficient data clustering method for very large databases.
    4. (2005). Blumenthal RS: Relation of serum uric acid with metabolic risk factors in asymptomaticmiddle-agedBrazilianmen.AmJCardiol 95:865–868,
    5. (2006). Campbell LV: Relationship between inflammation, insulin resistance and type 2 diabetes: ‘cause or effect’? Curr Diabetes Rev 2:195–211,
    6. (2007). Caprio S: The metabolic syndrome in children and adolescents. Lancet 369:2059–2061,
    7. (2004). D’Agostino RB Sr, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380–385,
    8. (1999). ES: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey,
    9. (2006). Eschwege E: Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 49:2599–2603,
    10. (1972). Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, withoutuseofthepreparativeultracentrifuge. Clin Chem 18:499–502,
    11. (2001). ExecutivesummaryoftheThirdReportof The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497,
    12. (2005). FordES,AjaniUA,MokdadAH:Themetabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878–881,
    13. (1982). GidezLI,MillerGJ,BursteinM,SlagleS,Eder HA:Separationandquantitationofsubclasses ofhumanplasmahighdensitylipoproteinsby a simple precipitation procedure.
    14. (2005). Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130–2137,
    15. (2006). GS: Distribution and metabolicsyndromecorrelatesofplasmaC-reactive protein in biracial (black-white) youngeradults:theBogalusaHeartStudy. Metabolism 55:699–705,
    16. (2007). GS: Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 56:792–798,
    17. (2006). Inflammation and changes in metabolic syndrome abnormalities
    18. (2005). Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42:987–1000,
    19. (2007). LJ: Perinatal and childhood origins of cardiovascular disease.
    20. (2005). LL: Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45:34–38,
    21. (2007). LM: Instability in the diagnosis of metabolicsyndromeinadolescents.Circulation 115:2316–2322,
    22. (1985). NaylorBA,TreacherDF,TurnerRC:Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419,
    23. (2007). Stroes ES: Highdensity lipoprotein attenuates inflammation and coagulation response on endotoxin challengeinhumans.ArteriosclerThrombVascBiol 27:1153–1158,
    24. (2004). The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 21:52–58,
    25. (2007). The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.